STING1 and Epstein-Barr virus infection: In favor of our hypothesis, we found that colony formation of EBV-infected B cells was attenuated at an early stage (before day 7 following EBV infection) under treatment with the STING agonist 10-carboxymethyl-9-acrianone (CMA).